Global Prescription Dermatological Drugs Market Research Report 2020

Global Prescription Dermatological Drugs Market Research Report 2020

Table of Contents
1 Prescription Dermatological Drugs Market Overview
1.1 Product Overview and Scope of Prescription Dermatological Drugs
1.2 Prescription Dermatological Drugs Segment by Type
1.2.1 Global Prescription Dermatological Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Prescription Dermatological Drugs Segment by Application
1.3.1 Prescription Dermatological Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Prescription Dermatological Drugs Market Size Estimates and Forecasts
1.4.1 Global Prescription Dermatological Drugs Revenue 2015-2026
1.4.2 Global Prescription Dermatological Drugs Sales 2015-2026
1.4.3 Prescription Dermatological Drugs Market Size by Region: 2020 Versus 2026
2 Global Prescription Dermatological Drugs Market Competition by Manufacturers
2.1 Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Prescription Dermatological Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Prescription Dermatological Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prescription Dermatological Drugs Market Competitive Situation and Trends
2.5.1 Prescription Dermatological Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Prescription Dermatological Drugs Players (Opinion Leaders)
3 Prescription Dermatological Drugs Retrospective Market Scenario by Region
3.1 Global Prescription Dermatological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Prescription Dermatological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Prescription Dermatological Drugs Market Facts & Figures by Country
3.3.1 North America Prescription Dermatological Drugs Sales by Country
3.3.2 North America Prescription Dermatological Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prescription Dermatological Drugs Market Facts & Figures by Country
3.4.1 Europe Prescription Dermatological Drugs Sales by Country
3.4.2 Europe Prescription Dermatological Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prescription Dermatological Drugs Sales by Region
3.5.2 Asia Pacific Prescription Dermatological Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prescription Dermatological Drugs Market Facts & Figures by Country
3.6.1 Latin America Prescription Dermatological Drugs Sales by Country
3.6.2 Latin America Prescription Dermatological Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
3.7.2 Middle East and Africa Prescription Dermatological Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prescription Dermatological Drugs Historic Market Analysis by Type
4.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
4.2 Global Prescription Dermatological Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Prescription Dermatological Drugs Price Market Share by Type (2015-2020)
4.4 Global Prescription Dermatological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Prescription Dermatological Drugs Historic Market Analysis by Application
5.1 Global Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
5.2 Global Prescription Dermatological Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Prescription Dermatological Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Prescription Dermatological Drugs Business
6.1 Johnson & Johnson
6.1.1 Corporation Information
6.1.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Johnson & Johnson Products Offered
6.1.5 Johnson & Johnson Recent Development
6.2 Merck
6.2.1 Merck Prescription Dermatological Drugs Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Bayer
6.3.1 Bayer Prescription Dermatological Drugs Production Sites and Area Served
6.3.2 Bayer Description, Business Overview and Total Revenue
6.3.3 Bayer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Bayer Products Offered
6.3.5 Bayer Recent Development
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Prescription Dermatological Drugs Production Sites and Area Served
6.4.2 Mylan Pharmaceuticals Description, Business Overview and Total Revenue
6.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mylan Pharmaceuticals Products Offered
6.4.5 Mylan Pharmaceuticals Recent Development
6.5 Pfizer
6.5.1 Pfizer Prescription Dermatological Drugs Production Sites and Area Served
6.5.2 Pfizer Description, Business Overview and Total Revenue
6.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Pfizer Products Offered
6.5.5 Pfizer Recent Development
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Prescription Dermatological Drugs Production Sites and Area Served
6.6.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.6.3 F. Hoffmann-La Roche Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 F. Hoffmann-La Roche Products Offered
6.6.5 F. Hoffmann-La Roche Recent Development
6.7 Allergan
6.6.1 Allergan Prescription Dermatological Drugs Production Sites and Area Served
6.6.2 Allergan Description, Business Overview and Total Revenue
6.6.3 Allergan Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Allergan Products Offered
6.7.5 Allergan Recent Development
6.8 Bausch Health
6.8.1 Bausch Health Prescription Dermatological Drugs Production Sites and Area Served
6.8.2 Bausch Health Description, Business Overview and Total Revenue
6.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Bausch Health Products Offered
6.8.5 Bausch Health Recent Development
6.9 PharmaDerm Pharmaceuticals
6.9.1 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Production Sites and Area Served
6.9.2 PharmaDerm Pharmaceuticals Description, Business Overview and Total Revenue
6.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 PharmaDerm Pharmaceuticals Products Offered
6.9.5 PharmaDerm Pharmaceuticals Recent Development
6.10 Allergan Inamed Corporation
6.10.1 Allergan Inamed Corporation Prescription Dermatological Drugs Production Sites and Area Served
6.10.2 Allergan Inamed Corporation Description, Business Overview and Total Revenue
6.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Allergan Inamed Corporation Products Offered
6.10.5 Allergan Inamed Corporation Recent Development
7 Prescription Dermatological Drugs Manufacturing Cost Analysis
7.1 Prescription Dermatological Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prescription Dermatological Drugs
7.4 Prescription Dermatological Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prescription Dermatological Drugs Distributors List
8.3 Prescription Dermatological Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Prescription Dermatological Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prescription Dermatological Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Prescription Dermatological Drugs by Type (2021-2026)
10.2 Prescription Dermatological Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prescription Dermatological Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Prescription Dermatological Drugs by Application (2021-2026)
10.3 Prescription Dermatological Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prescription Dermatological Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Prescription Dermatological Drugs by Region (2021-2026)
10.4 North America Prescription Dermatological Drugs Estimates and Projections (2021-2026)
10.5 Europe Prescription Dermatological Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Prescription Dermatological Drugs Estimates and Projections (2021-2026)
10.7 Latin America Prescription Dermatological Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Prescription Dermatological Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Prescription Dermatological Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Prescription Dermatological Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Prescription Dermatological Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Prescription Dermatological Drugs Manufacturers Covered in This Study
Table 5. Global Prescription Dermatological Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Prescription Dermatological Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Prescription Dermatological Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Prescription Dermatological Drugs Average Price (USD/Units) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Prescription Dermatological Drugs Sales Sites and Area Served
Table 11. Manufacturers Prescription Dermatological Drugs Product Types
Table 12. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatological Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Prescription Dermatological Drugs Players
Table 16. Global Prescription Dermatological Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Prescription Dermatological Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Prescription Dermatological Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Prescription Dermatological Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Prescription Dermatological Drugs Sales Share by Type (2015-2020)
Table 42. Global Prescription Dermatological Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Prescription Dermatological Drugs Revenue Share by Type (2015-2020)
Table 44. Global Prescription Dermatological Drugs Price (USD/Units) by Type (2015-2020)
Table 45. Global Prescription Dermatological Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Prescription Dermatological Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Johnson & Johnson Prescription Dermatological Drugs Corporation Information
Table 49. Johnson & Johnson Description and Business Overview
Table 50. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 51. Johnson & Johnson Main Product
Table 52. Johnson & Johnson Recent Development
Table 53. Merck Prescription Dermatological Drugs Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Bayer Prescription Dermatological Drugs Corporation Information
Table 59. Bayer Corporation Information
Table 60. Bayer Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 61. Bayer Main Product
Table 62. Bayer Recent Development
Table 63. Mylan Pharmaceuticals Prescription Dermatological Drugs Corporation Information
Table 64. Mylan Pharmaceuticals Corporation Information
Table 65. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 66. Mylan Pharmaceuticals Main Product
Table 67. Mylan Pharmaceuticals Recent Development
Table 68. Pfizer Prescription Dermatological Drugs Corporation Information
Table 69. Pfizer Corporation Information
Table 70. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 71. Pfizer Main Product
Table 72. Pfizer Recent Development
Table 73. F. Hoffmann-La Roche Prescription Dermatological Drugs Corporation Information
Table 74. F. Hoffmann-La Roche Corporation Information
Table 75. F. Hoffmann-La Roche Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 76. F. Hoffmann-La Roche Main Product
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Allergan Prescription Dermatological Drugs Corporation Information
Table 79. Allergan Corporation Information
Table 80. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 81. Allergan Main Product
Table 82. Allergan Recent Development
Table 83. Bausch Health Prescription Dermatological Drugs Corporation Information
Table 84. Bausch Health Corporation Information
Table 85. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 86. Bausch Health Main Product
Table 87. Bausch Health Recent Development
Table 88. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Corporation Information
Table 89. PharmaDerm Pharmaceuticals Corporation Information
Table 90. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 91. PharmaDerm Pharmaceuticals Main Product
Table 92. PharmaDerm Pharmaceuticals Recent Development
Table 93. Allergan Inamed Corporation Prescription Dermatological Drugs Corporation Information
Table 94. Allergan Inamed Corporation Corporation Information
Table 95. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 96. Allergan Inamed Corporation Main Product
Table 97. Allergan Inamed Corporation Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Prescription Dermatological Drugs Distributors List
Table 101. Prescription Dermatological Drugs Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Prescription Dermatological Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Prescription Dermatological Drugs Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Prescription Dermatological Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Prescription Dermatological Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Prescription Dermatological Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Prescription Dermatological Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Prescription Dermatological Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Prescription Dermatological Drugs Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Prescription Dermatological Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Prescription Dermatological Drugs
Figure 2. Global Prescription Dermatological Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Prescription Dermatological Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Prescription Dermatological Drugs Sales Capacity (K Units) (2015-2026)
Figure 17. Global Prescription Dermatological Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Prescription Dermatological Drugs Sales Share by Manufacturers in 2020
Figure 19. Global Prescription Dermatological Drugs Revenue Share by Manufacturers in 2019
Figure 20. The Global 5 and 10 Largest Players: Market Share by Prescription Dermatological Drugs Revenue in 2019
Figure 21. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Figure 23. Global Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 24. Global Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Figure 25. Global Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 26. North America Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 27. North America Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 28. U.S. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. U.S. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Canada Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Canada Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 33. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 34. Germany Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Germany Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. France Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. France Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. U.K. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Italy Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Italy Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Russia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Russia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 45. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 46. China Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. China Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Japan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Japan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. South Korea Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. South Korea Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. India Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. India Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Australia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Australia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Taiwan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Taiwan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Indonesia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Indonesia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Thailand Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Thailand Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Malaysia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Malaysia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Philippines Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Philippines Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Vietnam Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Vietnam Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Latin America Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 69. Latin America Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 70. Mexico Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Mexico Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Brazil Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Brazil Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Argentina Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 77. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 78. Turkey Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Saudi Arabia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Saudi Arabia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. U.A.E Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. U.A.E Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Sales Market Share of Prescription Dermatological Drugs by Type (2015-2020)
Figure 85. Sales Market Share of Prescription Dermatological Drugs by Type in 2019
Figure 86. Revenue Share of Prescription Dermatological Drugs by Type (2015-2020)
Figure 87. Revenue Market Share of Prescription Dermatological Drugs by Type in 2019
Figure 88. Global Prescription Dermatological Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 89. Global Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Figure 90. Global Prescription Dermatological Drugs Sales Market Share by Application in 2019
Figure 91. Global Revenue Share of Prescription Dermatological Drugs by Application (2015-2020)
Figure 92. Global Revenue Share of Prescription Dermatological Drugs by Application in 2020
Figure 93. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. PharmaDerm Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Allergan Inamed Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Price Trend of Key Raw Materials
Figure 104. Manufacturing Cost Structure of Prescription Dermatological Drugs
Figure 105. Manufacturing Process Analysis of Prescription Dermatological Drugs
Figure 106. Prescription Dermatological Drugs Industrial Chain Analysis
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. North America Prescription Dermatological Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. North America Prescription Dermatological Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Prescription Dermatological Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Prescription Dermatological Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Prescription Dermatological Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Prescription Dermatological Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Prescription Dermatological Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Prescription Dermatological Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Prescription Dermatological Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Prescription Dermatological Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs